Filipinai - anglų - FDA (Food And Drug Administration)

20170223094202 - singapore - medtronic philippines, inc. - medtronic philippines, inc.

Filipinai - anglų - FDA (Food And Drug Administration)

20170223094202 - singapore - medtronic philippines, inc. - medtronic philippines, inc.

Filipinai - anglų - FDA (Food And Drug Administration)

20170223094202 - singapore - medtronic philippines, inc. - medtronic philippines, inc.

Filipinai - anglų - FDA (Food And Drug Administration)

20170223094202 - singapore - medtronic philippines, inc. - medtronic philippines, inc.

Filipinai - anglų - FDA (Food And Drug Administration)

20170217142134 - singapore - transmedic philippines, inc. - transmedic philippines, inc.

Filipinai - anglų - FDA (Food And Drug Administration)

20170217142134 - singapore - transmedic philippines, inc. - transmedic philippines, inc.

Filipinai - anglų - FDA (Food And Drug Administration)

20170217142134 - singapore - transmedic philippines, inc. - transmedic philippines, inc.

Singapūras - anglų - HSA (Health Sciences Authority)

singapore smart tech pte. ltd. - dental - dental devices designed to influence the shape and/or function of the stomatognathic system through the application of physical force. it includes orthodontic anchor plate, orthodontic anchoring screw, orthodontic arch wire, orthodontic arch wire/bracket fixation ring, orthodontic bands, orthodontic brackets, orthodontic bracket adhesive, orthodontic clasps, orthodontic chin cap, orthodontic extraoral headgear, orthodontic face bow, orthodontic ligature, orthodontic magnet, orthodontic spring, orthodontic tube, orthodontic wire. gmdn no. for orthodontic wires is 16204

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

seqirus, inc. - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (mdck cell derived, propiolactone inactivated) (unii: qwjhw3wexs) (influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (mdck cell derived, propiolactone inactivated) - unii:55qh9pjkdv) - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (mdck cell derived, propiolactone inactivated) 15 ug in 0.5 ml

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

seqirus pty ltd - influenza a virus a/singapore/gp1908/2015 ivr-180a (h1n1) antigen (propiolactone inactivated) (unii: 9jwn7vdq7n) (influenza a virus a/singapore/gp1908/2015 ivr-180a (h1n1) hemagglutinin antigen (propiolactone inactivated) - unii:u6c4gj6wzg), influenza a virus a/singapore/infimh-16-0019/2016 ivr-186 (h3n2) antigen (propiolactone inactivated) (unii: a5wli8wk8a) (influenza a virus a/singapore/infimh-16-0019/2016 ivr-186 (h3n2) hemagglutinin antigen (propiolactone inactivated) - unii:37h6eg2naq), influenza b vi - influenza a virus a/singapore/gp1908/2015 ivr-180a (h1n1) hemagglutinin antigen (propiolactone inactivated) 15 ug in 0.5 ml - afluria® quadrivalent is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza a subtype viruses and type b viruses contained in the vaccine. afluria quadrivalent is approved for use in persons 5 years of age and older. afluria quadrivalent is contraindicated in individuals with known severe allergic reactions (e.g., anaphylaxis) to any component of the vaccine including egg protein, or to a previous dose of any influenza vaccine (see description [11]) . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to afluria quadrivalent during pregnancy. women who are vaccinated with afluria quadrivalent during pregnancy are encouraged to enroll in the registry by calling 1-855-358-8966 or sending an email to seqirus at us.medicalinformation@seqirus.com. risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated backg